COVID-19 shots for healthy younger adults and children will no longer be routinely approved under a major new policy shift unveiled Tuesday by the Trump administration.

Tourmaline Bio disclosed results for a potential rival to a Novo Nordisk drug. Elsewhere, data emerged for a psychedelic and CRISPR Therapeutics expanded its toolkit.

NewYork-Presbyterian Health reduced its workforce by 2%, or about 1,000 employees. Nurses voiced concerns that the layoffs unnecessarily harmed care.

U.S. President Donald Trump signed an executive order this week to lower the cost of prescription drugs in the United States by requiring drug companies to match the lower prices found in other countr ...

Regional initiative pairs tomorrow’s talent with today’s top creatives for a day of high‑impact mentorship, masterclasses, ...

HHS Secretary Robert F. Kennedy Jr. and biopharmas will negotiate drug prices individually. Kennedy could "propose a ...

U.S. stocks soared Monday as investors celebrated major progress on a U.S.-China trade deal. The Dow added over 1,100 points, ...

The order is a blow to the pharmaceutical industry, which is already bracing for Trump’s planned tariffs on prescription ...

the highest number recorded in a month since Challenger began reporting on job cut announcements in 1989," the firm stated in a May 1 feature on their research. "With the exclusion of April 2020 ...

Job cuts will affect employees at NREL’s headquarters in Golden, Colorado. Image: Dennis Schroeder/NREL The US National Renewable Energy Lab (NREL) has laid off 114 employees as proposed federal ...

The retail sector slashed more than 64,000 jobs during the first four months of 2025—a triple-digit percentage increase from the job cuts announced at the same time last year. April saw the most ...